A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer: An Illinois cancer center study Article Letter uri icon

Overview

MeSH Major

  • Genetic Predisposition to Disease
  • Leukemia, Myeloid
  • Mutation

publication date

  • January 1994

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(19940301)73:5<1536::AID-CNCR2820730538>3.0.CO;2-1

PubMed ID

  • 8111726

Additional Document Info

start page

  • 1536

end page

  • 7

volume

  • 73

number

  • 5